Mckesson Corporation Intrinsic Value Calculation – MCKESSON CORPORATION Reports First Quarter Earnings for FY2024
August 17, 2023
🌥️Earnings Overview
For the first quarter of FY2024, MCKESSON CORPORATION ($NYSE:MCK) reported total revenue of USD 74483.0 million, a 10.9% increase from the same quarter the previous year. Net income for the quarter surged 24.7%, reaching USD 958.0 million.
Share Price
Overall, MCKESSON CORPORATION’s first quarter earnings report was encouraging as the company continues to expand its market share in the health care industry. Through its focus on product innovation and customer service, MCKESSON CORPORATION is well positioned to continue to drive growth in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Mckesson Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 284.04k | 3.75k | 1.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Mckesson Corporation. More…
| Operations | Investing | Financing |
| 5.05k | -730 | -4.03k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Mckesson Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 64.1k | 65.34k | -11.88 |
Key Ratios Snapshot
Some of the financial key ratios for Mckesson Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.1% | 18.1% | 1.7% |
| FCF Margin | ROE | ROA |
| 1.6% | -179.4% | 4.8% |
Analysis – Mckesson Corporation Intrinsic Value Calculation
At GoodWhale, we have conducted an analysis of MCKESSON CORPORATION‘s wellbeing. We have used our proprietary Valuation Line to calculate the fair value of a MCKESSON CORPORATION share, which is around $321.8. Currently, MCKESSON CORPORATION stock is traded at $413.1, which means it is overvalued by 28.4%. We recommend investors to take caution when considering an investment in MCKESSON CORPORATION and to do their own research before making any decisions. More…
Peers
In the healthcare sector, McKesson Corp competes against Cardinal Health Inc, AmerisourceBergen Corp, and Sigma Healthcare Ltd. These companies are all major players in the healthcare industry, and each one brings something unique to the table. However, McKesson Corp is the largest of these companies, and its size gives it a significant competitive advantage.
– Cardinal Health Inc ($NYSE:CAH)
Cardinal Health Inc is a healthcare services and products company that operates in two segments: Pharmaceutical and Medical. The company’s Pharmaceutical segment includes sales of branded, generic and over-the-counter pharmaceutical products, as well as nuclear pharmacy services. The Medical segment provides a range of medical products and services, including surgical and medical products, medical devices and laboratory products and services. Cardinal Health Inc has a market cap of 18.55B as of 2022. The company’s Return on Equity for the same period is 55.12%.
– AmerisourceBergen Corp ($NYSE:ABC)
AmerisourceBergen is one of the world’s largest pharmaceutical services companies. It offers a range of services and products to healthcare providers and pharmaceutical companies. The company has a market cap of 29.64B as of 2022 and a return on equity of 417.0%. AmerisourceBergen is a publicly traded company listed on the New York Stock Exchange.
– Sigma Healthcare Ltd ($ASX:SIG)
Sigma Healthcare is a leading full-line wholesale and distribution company that services pharmacies across Australia. The company has a market capitalisation of $693.83 million as of March 2022 and a return on equity of 0.46%. Sigma Healthcare is a diversified healthcare company with operations in both pharmacy and hospital sectors. The company’s primary activities include the wholesale distribution of pharmaceuticals, medical and surgical supplies. Sigma Healthcare also owns and operates a number of community pharmacies across Australia.
Summary
McKesson Corporation reported strong financial results for the first quarter of FY2024 with total revenue of USD 74483.0 million, a 10.9% year-over-year increase. Net income increased significantly to USD 958.0 million, representing a 24.7% growth compared to the same period last year. Investors should be pleased with the company’s performance as it shows steady growth in revenue and profits, generating positive returns on investment. This is a good indicator that McKesson Corporation is well-positioned to continue its growth trajectory in the future.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
